Logo image of EXAI.MI

EXPERT.AI SPA (EXAI.MI) Stock Fundamental Analysis

Europe - Euronext Milan - BIT:EXAI - IT0004496029 - Common Stock

1.654 EUR
-0.01 (-0.36%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

2

Taking everything into account, EXAI scores 2 out of 10 in our fundamental rating. EXAI was compared to 113 industry peers in the Software industry. EXAI may be in some trouble as it scores bad on both profitability and health. EXAI is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

EXAI had negative earnings in the past year.
In the past year EXAI has reported a negative cash flow from operations.
EXAI had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: EXAI reported negative operating cash flow in multiple years.
EXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFEXAI.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M

1.2 Ratios

EXAI's Return On Assets of -20.72% is on the low side compared to the rest of the industry. EXAI is outperformed by 84.96% of its industry peers.
EXAI has a Return On Equity of -55.60%. This is amonst the worse of the industry: EXAI underperforms 84.07% of its industry peers.
Industry RankSector Rank
ROA -20.72%
ROE -55.6%
ROIC N/A
ROA(3y)-17.14%
ROA(5y)-11.81%
ROE(3y)-30.65%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
EXAI.MI Yearly ROA, ROE, ROICEXAI.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10 -20 -30 -40

1.3 Margins

EXAI has a Gross Margin of 82.85%. This is in the better half of the industry: EXAI outperforms 73.45% of its industry peers.
In the last couple of years the Gross Margin of EXAI has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for EXAI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.85%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.01%
EXAI.MI Yearly Profit, Operating, Gross MarginsEXAI.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

3

2. Health

2.1 Basic Checks

EXAI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for EXAI has been increased compared to 1 year ago.
The number of shares outstanding for EXAI has been increased compared to 5 years ago.
Compared to 1 year ago, EXAI has an improved debt to assets ratio.
EXAI.MI Yearly Shares OutstandingEXAI.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
EXAI.MI Yearly Total Debt VS Total AssetsEXAI.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 1.20, we must say that EXAI is in the distress zone and has some risk of bankruptcy.
EXAI's Altman-Z score of 1.20 is on the low side compared to the rest of the industry. EXAI is outperformed by 69.91% of its industry peers.
A Debt/Equity ratio of 0.52 indicates that EXAI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.52, EXAI is doing worse than 65.49% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Altman-Z 1.2
ROIC/WACCN/A
WACC8.43%
EXAI.MI Yearly LT Debt VS Equity VS FCFEXAI.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.77 indicates that EXAI should not have too much problems paying its short term obligations.
EXAI has a Current ratio of 1.77. This is in the better half of the industry: EXAI outperforms 66.37% of its industry peers.
EXAI has a Quick Ratio of 1.77. This is a normal value and indicates that EXAI is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.77, EXAI is in the better half of the industry, outperforming 69.03% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.77
Quick Ratio 1.77
EXAI.MI Yearly Current Assets VS Current LiabilitesEXAI.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

5

3. Growth

3.1 Past

EXAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.15%, which is quite impressive.
Looking at the last year, EXAI shows a quite strong growth in Revenue. The Revenue has grown by 11.83% in the last year.
EXAI shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -9.05% yearly.
EPS 1Y (TTM)56.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.83%
Revenue 1Y (TTM)11.83%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%30.88%

3.2 Future

The Earnings Per Share is expected to grow by 33.21% on average over the next years. This is a very strong growth
EXAI is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 21.03% yearly.
EPS Next Y90.91%
EPS Next 2Y44.6%
EPS Next 3Y33.21%
EPS Next 5YN/A
Revenue Next Year39.19%
Revenue Next 2Y26.95%
Revenue Next 3Y21.03%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EXAI.MI Yearly Revenue VS EstimatesEXAI.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 10M 20M 30M 40M
EXAI.MI Yearly EPS VS EstimatesEXAI.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2 -0.3

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EXAI. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 162.16 indicates a quite expensive valuation of EXAI.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXAI indicates a slightly more expensive valuation: EXAI is more expensive than 64.60% of the companies listed in the same industry.
EXAI is valuated expensively when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 162.16
EXAI.MI Price Earnings VS Forward Price EarningsEXAI.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as EXAI.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 37.64
EXAI.MI Per share dataEXAI.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.1 -0.1 0.2

4.3 Compensation for Growth

EXAI's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
EXAI's earnings are expected to grow with 33.21% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.6%
EPS Next 3Y33.21%

0

5. Dividend

5.1 Amount

EXAI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

EXPERT.AI SPA

BIT:EXAI (12/12/2025, 7:00:00 PM)

1.654

-0.01 (-0.36%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)09-30 2025-09-30
Earnings (Next)N/A N/A
Inst Owners3.28%
Inst Owner ChangeN/A
Ins Owners8.64%
Ins Owner ChangeN/A
Market Cap187.05M
Revenue(TTM)23.00M
Net Income(TTM)-13.96M
Analysts42.22
Price Target1.43 (-13.54%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-133.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 162.16
P/S 8.13
P/FCF N/A
P/OCF N/A
P/B 7.45
P/tB 24.37
EV/EBITDA 37.64
EPS(TTM)-0.14
EYN/A
EPS(NY)0.01
Fwd EY0.62%
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS0.2
BVpS0.22
TBVpS0.07
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -20.72%
ROE -55.6%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.85%
FCFM N/A
ROA(3y)-17.14%
ROA(5y)-11.81%
ROE(3y)-30.65%
ROE(5y)-21.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.1%
GM growth 5Y1.01%
F-Score4
Asset Turnover0.34
Health
Industry RankSector Rank
Debt/Equity 0.52
Debt/FCF N/A
Debt/EBITDA 2.58
Cap/Depr 89.47%
Cap/Sales 32.82%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.77
Quick Ratio 1.77
Altman-Z 1.2
F-Score4
WACC8.43%
ROIC/WACCN/A
Cap/Depr(3y)100.55%
Cap/Depr(5y)114.56%
Cap/Sales(3y)34.83%
Cap/Sales(5y)34.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%28.83%
EPS Next Y90.91%
EPS Next 2Y44.6%
EPS Next 3Y33.21%
EPS Next 5YN/A
Revenue 1Y (TTM)11.83%
Revenue growth 3Y-3.77%
Revenue growth 5Y-9.05%
Sales Q2Q%30.88%
Revenue Next Year39.19%
Revenue Next 2Y26.95%
Revenue Next 3Y21.03%
Revenue Next 5YN/A
EBIT growth 1Y-441.5%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year258.97%
EBIT Next 3Y70.12%
EBIT Next 5Y66.89%
FCF growth 1Y-217.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-235.78%
OCF growth 3YN/A
OCF growth 5YN/A

EXPERT.AI SPA / EXAI.MI FAQ

What is the fundamental rating for EXAI stock?

ChartMill assigns a fundamental rating of 2 / 10 to EXAI.MI.


Can you provide the valuation status for EXPERT.AI SPA?

ChartMill assigns a valuation rating of 1 / 10 to EXPERT.AI SPA (EXAI.MI). This can be considered as Overvalued.


Can you provide the profitability details for EXPERT.AI SPA?

EXPERT.AI SPA (EXAI.MI) has a profitability rating of 1 / 10.


Can you provide the financial health for EXAI stock?

The financial health rating of EXPERT.AI SPA (EXAI.MI) is 3 / 10.